ARCA Biopharma (Genvara Biopharma)

Genotype-guided cardiovascular therapeutics

Privately held: no public share price · United States

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Bucindolol(Gencaro)No recent activity
Phase 2
Beta-1/beta-2 adrenergic receptor (genotype-guided)Small molecule
Heart Failure

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.